why choose us

First received: April 29, 2026

Clinical Trial: Resveratrol for Endothelial Dysfunction and Metabolic Control in Type 2 Diabetes

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Type 2 Diabetes Mellitus
Endothelial Dysfunction

Study Type: INTERVENTIONAL


Official Title: Effectiveness of Resveratrol Addition in Improving Endothelial Dysfunction and Metabolic Control in Type 2 Diabetes Mellitus Patients: A Randomized Controlled Trial

Brief Summary: Type 2 diabetes mellitus is associated with endothelial dysfunction, which contributes to increased cardiovascular risk. Chronic hyperglycemia induces oxidative stress and reduces nitric oxide bioavailability, leading to impaired endothelial function. Resveratrol, a natural polyphenol with antioxidant and anti-inflammatory properties, has been shown to improve endothelial function in experimental studies.This randomized controlled trial aims to evaluate the effectiveness of resveratrol supplementation in improving…

Read more